Using the percentage of bone marrow blast cells in combination with mutation-specific ctDNA measurements in peripheral blood, we estimated population parameters of a mixed effect model for a cohort of 7 NPM1 and 3 IDH2 mutated AML patients. The gene discussed is NPM1; the disease is acute myeloid leukemia.